Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1α,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor β

Cell Growth and Differentiation

Volumn 10, Issue 10, 1999, Pages 705-712

  Kanatani, Yasuhiro ^a,b   Kasukabe, Takashi ^a   Okabe Kado, Junko ^a   Yamamoto Yamaguchi, Yuri ^a   Nagata, Naokazu ^b   Motoyoshi, Kazuo ^b   Honma, Yoshio ^a,c  

^a SAITAMA CANCER CENTER   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Haematology Division   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD14 ANTIGEN; COMPLEMENTARY RNA; DEXAMETHASONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL SURVIVAL; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; RETINOBLASTOMA;

ANTIGENS, CD14; APOPTOSIS; BCL-X PROTEIN; CALCITRIOL; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DEXAMETHASONE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS; U937 CELLS;

EID: 0032713132     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 3-induced monocylic differentiation of myeloid leukemia cells. Anticancer Res., 11: 181-186, 1991.
2. 3-induced terminal monocytic differentiation of human leukemic cell lines. J. Immunol., 150: 2418-2430, 1993.
3. Kanatani, Y., Kasukabe, T., Okabe-Kado, J., Hayashi, S., Yamamoto-Yamaguchi, Y., Motoyoshi, K., Nagata, N., and Honma, Y. Transforming growth factor β and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth Differ., 7: 187-186, 1996.
4. 1 cyclins. Cell, 73: 1058-1065, 1993.
5. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
6. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
7. White, E. Life, death, and the pursuit of apoptosis. Genes Dev., 10: 1-15, 1996.
8. Fraser, A., and Evan, G. A license to kill. Cell, 85: 781-784, 1996.
9. Sedlak, T. W., Oltvi, Z. N., Yang, E., Wang, K., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. Multiple Bcl-2 family members demonstrate selective dimerization with Bax. Proc. Natl. Acad. Sci. USA, 92: 7834-7838, 1995.
10. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997.
11. Rogatsky, I., Trowbridge, J. M., and Garabedian, M. J. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol. Cell. Biol., 17: 3181-3193, 1997.
12. Miyashita, T., Mami, U., Inoue, T., Reed, J. C., and Yamada, M. Bcl-2 relieves the trans-repressive function of the glucocorticoid receptor and inhibits the activation of CPP32-like cysteine proteases. Biochem. Biophys. Res. Commun., 233: 781-787, 1997.
13. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
14. Yamochi, T., Kitabayashi, A., Hirokawa, M., Miura, A. B., Onizuka, T., Mori, S., and Moriyama, M. Regulation of BCL-6 gene expression in human myeloid/monocytoid leukemic cells. Leukemia (Baltimore), 11: 694-700, 1997.
15. Sanz, C., Benito, A., Silva, M., Albella, B., Richard, C., Segovia, J. C., Insunza, A., Bueren, J. A., and Fernandez-Luna, J. L. The expression of Bcl-x is down-regulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood, 89: 3199-3204, 1997.
16. L. Cell Growth Differ., 8: 1083-1089, 1997.
17. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., and Massague, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell, 62: 175-185, 1990.
18. Massague, J. The transforming growth factor-β family. Annu. Rev. Cell Biol., 6: 597-641, 1990.
19. Drexler, H. C. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA, 94: 855-860, 1997.
20. L and pro-apoptotic activity. J. Biol. Chem., 272: 24101-24104, 1997.
21. Pollman, M. J., Hall, J. L., Mann, M. J., Zhang, L., and Gibbons, G. H. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat. Med., 4: 222-227, 1998.
22. Zhang, C., Ao, Z., Seth, A., and Schlossman, S. F. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J. Immunol., 157: 3980-3987, 1996.
23. Heidenreich, S., Schmidt, M., August, C., Cullen, P., Rademaekers, A., and Pauels, H-G. Regulation of human monocyte apoptosis by the CD14 molecule. J. Immunol., 159: 3178-3188, 1997.
24. Koopman, G., Reutelingsperger, C. P. M., Kuijten, G. A. M., Keehnen, R. M. J., Pals, S. T., and van Oers, M. H. J. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84: 1415-1420, 1994.
25. Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., van Schie, R. C. A. A., LaFace, D. M., and Green, D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and abl. J. Exp. Med., 182: 1545-1556, 1995.
26. Thompson, E. B. Apoptosis and steroid hormones. Mol. Endocrinol., 8: 665-673, 1994.
27. Powers, J. H., Hillmann, A. G., Tang, D. C., and Harmon, J. M. Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells. Cancer Res., 53: 4059-4065, 1993.
28. Shen, L., Guyre, P. M., and Fanger, M. W. Direct stimulation of ADCC by cloned γ interferon is not ablated by glucocorticoids: studies using a human monocyte-like cell line (U-937). Mol. Immunol., 21: 167-173, 1984.
29. Nordeen, S. K., Moyer, M. L., and Bona, B. J. The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology, 134: 1723-1732, 1994.
30. 1-accumulation. Blood, 89: 2938-2950, 1997.
31. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev., 10: 142-153, 1996.
32. Millard, S. S., Yan, J. S., Nguyen, H., Pagano, M., Kiyokawa, H., and Koff, A. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem., 272: 7093-7098, 1977.
33. Ragg, S. J., Koga, S., Berg, K. A., and Ochi, A. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J. Immunol., 161: 1390-1398, 1998.
34. Nockher, W. A., and Scheberich, J. E. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J. Immunol., 158: 1345-1352, 1997.
35. Marchant, A., Duchow, J., Delville, J. P., and Goldman, M. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. Eur. J. Immunol., 22: 1663-1665, 1992.
36. Makishima, M., Umesono, K., Shudo, K., Naoe, T., Kishi, K., and Honma, Y. Induction of differentiation in acute promyelocytic leukemia cells by 9-cis-retinoic acid α-tocopherol ester (9-cis-tretinoin tocoferil). Blood, 91: 4715-4726, 1998.
37. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
38. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.